Amkor Technology, Inc. Profile Avatar - Palmy Investing

Amkor Technology, Inc.

Amkor Technology, Inc. provides outsourced semiconductor packaging and test services in the United States, Japan, Europe, the Middle East, Africa, and the rest of the Asia Pacific. It offers turnkey packaging and test services, including semiconductor wa…
Semiconductors
US, Tempe [HQ]

FA

Fundamental Analysis · Most Recent Quarter

It is important to understand the FA Algorithm and the criterias before valuing it as a top-tier resource.

Read Rationale
Framework:
Valuation 14% Weak
Profitability n.A. n.A.
Fin. Growth 17% Weak
Leverage & Liquidity 33% Weak
Per Share Metrics 0% Bad
Fin. Health n.A. n.A.
Fundamentals

Valuation

Metric Q4 Q1 Δ in %
EV/EBITDA 37.95 36.65 26.57
Graham Fair Price -28.97 9.36 13.17
PEG 57.55 -0.66 -1.57
Price/Book -5.14 1.96 2.06
Price/Cash Flow 386.14 118.31 24.34
Prices/Earnings 91.01 33.22 17.39
Price/Sales 22.76 5.73 4.67
Price/FCF 386.14 118.31 24.34
Naive Interpretation member
01 - Valuation · Weak
Fundamentals

Profitability

Metric Q4 Q1 Δ in %
Gross Profit Margin -7.32 0.15 0.16
Operating Margin -40.87 0.05 0.09
ROA -49.26 < 0.005 0.02
ROE 0.03 0.01 -50.34
ROIC 0.02 0.01 -50.99
Naive Interpretation member
02 - Profitability · Not Interpreted
Fundamentals

Financial Growth

Metric Q4 Q1 Δ in %
Debt QOQ -0.07 0.15 -52.87
Dividends QOQ 0.05 < 0.005 -99.10
EBIT QOQ -0.05 -0.54 -1032.03
EPS QOQ -0.11 -0.50 -350.00
FCF QOQ 6.59 -0.80 -87.81
Revenue QOQ -0.04 -0.22 -474.05
Naive Interpretation member
03 - Financial Growth · Weak
Fundamentals

Leverage & Liquidity

Metric Q4 Q1 Δ in %
Assets Turnover n.A. n.A. n.A.
Days Inventory Outstanding (DIO) 24.02 25.60 6.56
Days Sales Outstanding (DSO) 59.06 72.10 22.09
Inventory Turnover 3.75 3.52 -6.16
Debt/Capitalization 0.25 0.24 -4.39
Quick Ratio 1.98 2.05 3.23
Naive Interpretation member
04 - Leverage & Liquidity · Weak
Fundamentals

Per Share Metrics

Metric Q4 Q1 Δ in %
Book Value 16.12 16.25 0.79
Cash 6.49 6.39 -1.46
Capex -0.97 -0.39 59.60
Free Cash Flow 1.37 0.27 -80.33
Revenue 7.13 5.55 -22.12
Naive Interpretation member
05 - Per Share Metrics · Bad
Fundamentals

Financial Health

Metric Q4 Q1 Δ in %
Current Ratio 2.31 2.34 1.22
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 0.83 0.76 -8.51
Naive Interpretation Member
06 - Financial Health · Bad
End of AMKR's Analysis
CIK: 1047127 CUSIP: 031652100 ISIN: US0316521006 LEI: - UEI: -
Secondary Listings
AMKR has no secondary listings inside our databases.